Is intra-arrest therapeutic hypothermia feasible during CPR, and does it improve outcomes?
What is the optimal dose and duration of post-cardiac arrest hypothermic targeted temperature management?
What is an appropriate mechanism and study design to evaluate the beneficial effects of hypothermia following acute myocardial infarction?
There is a need to employ new molecular tools to delineate the difference between beneficial and uncontrolled shock-induced hypothermia, because data on hypothermia and hemostasis are incomplete or lacking, especially on the duration, depth and type of hypothermia.
availability of targeted resource grant funding